Literature DB >> 8937828

Huntington's disease: translating a CAG repeat into a pathogenic mechanism.

M E MacDonald1, J F Gusella.   

Abstract

The specific pattern of neuronal cell death in Huntington's disease (HD) is triggered by an abnormal version of the huntingtin protein, which is produced by translation of the HD gene defect, an expanded CAG repeat in a novel 4p16.3 gene. The extended amino-terminal polyglutamine segment may act via the protein's inherent activity, increasing it or decreasing it in a graded fashion, or, alternatively, it may confer the ability to interact with a completely different set of cellular pathways, focusing attention on the HD protein's normal and abnormal physiological functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8937828     DOI: 10.1016/s0959-4388(96)80097-3

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  17 in total

1.  Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin.

Authors:  S H Li; A L Cheng; H Li; X J Li
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

2.  Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

Authors:  R J Carter; L A Lione; T Humby; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

Review 3.  Apoptosis in neural development and disease.

Authors:  N D Mazarakis; A D Edwards; H Mehmet
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

4.  A crystal structure of a model of the repeating r(CGG) transcript found in fragile X syndrome.

Authors:  Amit Kumar; Pengfei Fang; Hajeung Park; Min Guo; Kendall W Nettles; Matthew D Disney
Journal:  Chembiochem       Date:  2011-07-15       Impact factor: 3.164

5.  Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo.

Authors:  B R Leavitt; J A Guttman; J G Hodgson; G H Kimel; R Singaraja; A W Vogl; M R Hayden
Journal:  Am J Hum Genet       Date:  2000-12-20       Impact factor: 11.025

6.  Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity.

Authors:  O Hansson; A Petersén; M Leist; P Nicotera; R F Castilho; P Brundin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 7.  The early cellular pathology of Huntington's disease.

Authors:  X J Li
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

8.  Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization.

Authors:  Andreas Vitalis; Xiaoling Wang; Rohit V Pappu
Journal:  J Mol Biol       Date:  2008-09-18       Impact factor: 5.469

9.  An Analysis of Biomolecular Force Fields for Simulations of Polyglutamine in Solution.

Authors:  Aaron M Fluitt; Juan J de Pablo
Journal:  Biophys J       Date:  2015-09-01       Impact factor: 4.033

10.  DFNA5: hearing impairment exon instead of hearing impairment gene?

Authors:  L Van Laer; K Vrijens; S Thys; V F I Van Tendeloo; R J H Smith; D R Van Bockstaele; J-P Timmermans; G Van Camp
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.